Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the Brics: Challenges and Opportunities: Summary of a Joint Workshop by t

by Institute of Medicine , Board on Health Sciences Policy , Forum on Drug Discovery Development and
Save 17% Save 17%
Current price ₹4,975.00
Original price ₹5,970.00
Original price ₹5,970.00
Original price ₹5,970.00
(-17%)
₹4,975.00
Current price ₹4,975.00

Imported Edition - Ships in 18-21 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Paperback
  • ISBN13: 9780309285964
  • Binding: Paperback
  • Subject: N/A
  • Publisher: National Academies Press
  • Publisher Imprint: National Academies Press
  • Publication Date:
  • Pages: 218
  • Original Price: USD 48.0
  • Language: English
  • Edition: 1
  • Item Weight: 363 grams
  • BISAC Subject(s): Public Health

Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Medicine has hosted or co-hosted six domestic and international workshops addressing the global crisis of drug-resistant TB, with special attention to the BRICS countries - Brazil, Russia, India, China, and South Africa.

The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS is the summary of a workshop convened to address the current status of drug-resistant TB globally and in China. This report considers lessons learned from high burden countries; highlights global challenges to controlling the spread of drug-resistant strains; and discusses innovative strategies to advance and harmonize local and international efforts to prevent and treat drug-resistant TB. Additionally, the report examines the problem of MDR TB and emergent TB strains that are potentially untreatable with drugs available and considers the critical leadership role of the BRICS countries in addressing the threats and opportunities in drug-resistant TB.

Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us